Maternal-Fetal Medicine Research Program, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Maternal-Fetal Medicine Research Program, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Am J Obstet Gynecol. 2024 Jan;230(1):83.e1-83.e11. doi: 10.1016/j.ajog.2023.07.029. Epub 2023 Jul 23.
Crown-rump length discordance, defined as ≥10% discordance, has been investigated as an early sonographic marker of subsequent growth abnormalities and is associated with an increased risk of fetal loss in twin pregnancies. Previous studies have not investigated the prevalence of fetal aneuploidy or structural anomalies in twins with discordance or the independent association of crown-rump length discordance with adverse perinatal outcomes. Moreover, data are limited on cell-free DNA screening for aneuploidy in dichorionic twins with discordance.
This study aimed to evaluate whether crown-rump length discordance in dichorionic twins between 11 and 14 weeks of gestation is associated with a higher risk of aneuploidy, structural anomalies, or adverse perinatal outcomes and to assess the performance of cell-free DNA screening in dichorionic twin pregnancies with crown-rump length discordance.
This was a secondary analysis of a multicenter retrospective cohort study that evaluated the performance of cell-free DNA screening for the common trisomies in twin pregnancies from December 2011 to February 2020. For this secondary analysis, we included live dichorionic pregnancies with crown-rump length measurements between 11 and 14 weeks of gestation. First, we compared twin pregnancies with discordant crown-rump lengths with twin pregnancies with concordant crown-rump lengths and analyzed the prevalence of aneuploidy and fetal structural anomalies in either twin. Second, we compared the prevalence of a composite adverse perinatal outcome, which included preterm birth at <34 weeks of gestation, hypertensive disorders of pregnancy, stillbirth or miscarriage, small-for-gestational-age birthweight, and birthweight discordance. Moreover, we assessed the performance of cell-free DNA screening in pregnancies with and without crown-rump length discordance. Outcomes were compared with multivariable regression to adjust for confounders.
Of 987 dichorionic twins, 142 (14%) had crown-rump length discordance. The prevalence of aneuploidy was higher in twins with crown-rump length discordance than in twins with concordance (9.9% vs 3.9%, respectively; adjusted relative risk, 2.7; 95% confidence interval, 1.4-4.9). Similarly, structural anomalies (adjusted relative risk, 2.5; 95% confidence interval, 1.4-4.4]) and composite adverse perinatal outcomes (adjusted relative risk, 1.2; 95% confidence interval, 1.04-1.3) were significantly higher in twins with discordance. A stratified analysis demonstrated that even without other ultrasound markers, there were increased risks of aneuploidy (adjusted relative risk, 3.5; 95% confidence interval, 1.5-8.4) and structural anomalies (adjusted relative risk, 2.7; 95% confidence interval, 1.5-4.8) in twins with CRL discordance. Cell-free DNA screening had high negative predictive values for trisomy 21, trisomy 18, and trisomy 13, regardless of crown-rump length discordance, with 1 false-negative for trisomy 21 in a twin pregnancy with discordance.
Crown-rump length discordance in dichorionic twins is associated with an increased risk of aneuploidy, structural anomalies, and adverse perinatal outcomes, even without other sonographic abnormalities. Cell-free DNA screening demonstrated high sensitivity and negative predictive values irrespective of crown-rump length discordance; however, 1 false-negative result illustrated that there is a role for diagnostic testing. These data may prove useful in identifying twin pregnancies that may benefit from increased screening and surveillance and are not ascertained by other early sonographic markers.
顶臀长(CRL)差异≥10%被认为是随后生长异常的早期超声标志物,与双胎妊娠胎儿丢失风险增加相关。既往研究并未调查双胞胎中 CRL 差异与胎儿非整倍体或结构异常的相关性,也未调查 CRL 差异与不良围产结局的独立相关性。此外,关于 CRL 差异的二绒毛膜双胞胎非整倍体游离 DNA 筛查的数据有限。
本研究旨在评估妊娠 11-14 周时双绒毛膜双胞胎的 CRL 差异是否与非整倍体风险增加、结构异常或不良围产结局相关,并评估 CRL 差异的二绒毛膜双胞胎游离 DNA 筛查的性能。
这是一项多中心回顾性队列研究的二次分析,评估了 2011 年 12 月至 2020 年 2 月期间游离 DNA 筛查在双胎妊娠常见三体中的表现。对于本次二次分析,我们纳入了妊娠 11-14 周时 CRL 测量值存在差异的活产双绒毛膜妊娠。首先,我们比较了 CRL 差异的双胞胎妊娠与 CRL 一致的双胞胎妊娠,并分析了任一胎儿的非整倍体和结构异常的发生率。其次,我们比较了复合不良围产结局的发生率,包括<34 周早产、妊娠高血压疾病、死胎或流产、小于胎龄儿出生体重和出生体重差异。此外,我们评估了游离 DNA 筛查在存在和不存在 CRL 差异的妊娠中的性能。结果通过多变量回归进行比较,以调整混杂因素。
在 987 例双绒毛膜双胞胎中,有 142 例(14%)存在 CRL 差异。与 CRL 一致的双胞胎相比,CRL 差异的双胞胎中非整倍体的发生率更高(分别为 9.9%和 3.9%;调整后的相对风险,2.7;95%置信区间,1.4-4.9)。同样,结构异常(调整后的相对风险,2.5;95%置信区间,1.4-4.4])和复合不良围产结局(调整后的相对风险,1.2;95%置信区间,1.04-1.3)在 CRL 差异的双胞胎中显著更高。分层分析表明,即使没有其他超声标志物,CRL 差异的双胞胎也存在非整倍体(调整后的相对风险,3.5;95%置信区间,1.5-8.4)和结构异常(调整后的相对风险,2.7;95%置信区间,1.5-4.8)的风险增加。游离 DNA 筛查对于 21 三体、18 三体和 13 三体的阴性预测值均较高,无论 CRL 差异如何,在 1 例 CRL 差异的双胞胎妊娠中存在 1 例 21 三体假阴性。
双绒毛膜双胞胎的 CRL 差异与非整倍体、结构异常和不良围产结局的风险增加相关,即使没有其他超声异常也是如此。游离 DNA 筛查显示出较高的敏感性和阴性预测值,无论 CRL 差异如何;然而,1 例 21 三体假阴性结果表明存在诊断检测的作用。这些数据可能有助于识别可能受益于增加筛查和监测的双胎妊娠,而这些妊娠不能通过其他早期超声标志物确定。